Iron supplement in cancer patients receiving erythropoietin

J Clin Oncol. 2004 Nov 1;22(21):4428; author reply 4428-9. doi: 10.1200/JCO.2004.04.860.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Antineoplastic Agents / adverse effects*
  • Erythropoietin / therapeutic use*
  • Humans
  • Iron / administration & dosage*
  • Iron-Dextran Complex / administration & dosage*
  • Neoplasms / drug therapy
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Erythropoietin
  • Iron-Dextran Complex
  • Iron